Related Experiment Video
Updated: Jun 11, 2025

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Association between consensus-based nutrition pathway and growth faltering in infants with gastroschisis: A
Katie M Strobel1,2, Katelin Kramer3, Catherine Rottkamp4
1Department of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Insights
A new nutrition pathway significantly reduced growth faltering in infants with gastroschisis. This multicenter approach improved infant outcomes by focusing on early parenteral nutrition and human milk, leading to better growth by hospital discharge.
Area of Science:
- Pediatric Surgery
- Neonatal Nutrition
- Growth Monitoring
Background:
- Gastroschisis is associated with a high incidence of growth faltering, affecting 55% of infants by hospital discharge.
- A significant need exists to improve nutritional support and growth outcomes for neonates with gastroschisis.
- Previous research highlighted the challenges in managing growth faltering in this population.
Purpose of the Study:
- To assess the adherence and efficacy of a newly developed nutrition pathway for infants with gastroschisis.
- To evaluate the impact of the pathway on growth faltering rates at hospital discharge.
- To compare growth outcomes in infants before and after the pathway's implementation.
Main Methods:
- A multicenter nutrition pathway was developed and implemented across six California hospitals.
- The pathway emphasized early parenteral macronutrient provision, human milk utilization, and specific growth faltering treatments.
- Infants born before (n=126) and after (n=52) pathway initiation were compared for weight and linear growth faltering (z score decline ≥0.8).
Main Results:
- Adherence to the pathway components ranged from 58% to 95%.
- The incidence of weight or linear growth faltering at discharge decreased significantly post-pathway implementation (59.4% vs 36.2%, P=0.0068).
- The pathway was independently associated with reduced growth faltering (OR 0.35) and linear growth faltering (OR 0.24) at discharge, after adjusting for gestational age and fetal growth restriction.
Conclusions:
- Implementation of a multicenter nutrition pathway led to a significant reduction in growth faltering for infants with gastroschisis.
- The pathway effectively improved infant growth outcomes by hospital discharge.
- This standardized approach demonstrates a successful strategy for managing nutritional challenges in gastroschisis.
Background:
The University of California Fetal Consortium published that 55% of infants with gastroschisis develop growth faltering by hospital discharge. To address this problem, we developed a nutrition pathway emphasizing (1) early provision of parenteral macronutrients, (2) use of human milk, and (3) growth faltering treatment. This study's goals were to assess adherence to and efficacy of this pathway in infants with gastroschisis across six California hospitals.
Methods:
In 2015, the consortium standardized the care for infants with gastroschisis. To decrease growth faltering rates, between 2019 and 2020, nutrition guidelines were proposed, discussed, revised, and initiated. This study's primary outcome was weight or linear growth faltering (z score decline ≥0.8 in weight or length) at hospital discharge. Adherence measures were assessed.
Results:
One hundred twenty-six infants with gastroschisis were born prepathway; 52 were born postpathway. Median gestational age was similar between cohorts. Adherence to components of the pathway ranged from 58% to 95%. The proportion of infants with weight or linear growth faltering at discharge was lower after pathway initiation (59.4% vs 36.2%, P = 0.0068). Adjusting for gestational age and fetal growth restriction, the pathway was associated with decreased weight or linear growth faltering (odds ratio [OR] 0.35 [0.16-0.75], P = 0.0060) and decreased linear growth faltering (OR 0.24 [0.096-0.56], P = 0.0062) at discharge. Hypertriglyceridemia, cholestasis, and days to full feeds were similar to published cohorts.
Conclusion:
Fewer infants with gastroschisis experienced weight or length growth faltering at hospital discharge following the implementation of a multicenter nutrition pathway.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nature and Nurture
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inborn Errors of Metabolism
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

